Resumo

QUINTERO, Lisbeth et al. Cálculo del Índice de Pearl de etinilestradiol 30 mcg/drospirenona 3 mg (Genesa^®). Rev Obstet Ginecol Venez [online]. 2017, vol.77, n.1, pp.51-57. ISSN 0048-7732.

Objective: To calculate the Pearl index of Genesa^® in Venezuelan women. Methods: Phase IV prospective and open study. Patients received ethinylestradiol 30 mcg / drospirenone 3 mg (Genesa^®): one tablet daily from the first day of menstruation for 21 days; seven-day break and restart the eighth day. Results: 115 patients were admitted to the study, a Pearl index of 0.98 was obtained. Most common side effects: one pregnancy, weight gain, fluid retention, nausea, skin blemishes. One patient discontinued treatment for adverse effects (vomiting and nausea). Conclusions: Genesa^® presents an adequate Pearl Index in Venezuelan woman.

Palavras-chave : Oral Contraception; Ethinylestradiol; Drospirenone; Pearl Index.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )